U.S. VC Funding Falls 46% in April to $7.3B; Washington State Raises $190M in 21 Deals Led by Health and Biotech

U.S. venture capital investment plunged in April — down 46% from March to $7.3 billion and 43% year-over-year — while Washington state fared better with $190 million across 21 deals, helped by health and life-sciences financings.

BBlaze Bioscience